Do not come at me with your attitude or nonsense Son as nothing good will come of it.
For the benefit of actual investors / potential investors, Bevcanna is a start-up and having recently obtained said license from HC is now in a position to start generating significant revenue. One recent example (taken from Sedar) to show Bevcanna is not pre-revenue is below.
Also, the outstanding share count is 100M which is low in comparison to many peers in this growing space.
VANCOUVER, BC, Oct. 9, 2020 /CNW/ - Emerging leader in infused cannabis beverages,BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) ("BevCanna" or the"Company") announced today that its wholly owned subsidiary, Pure Therapy Products Corp. ("PureTherapy") has generated C$1.53 million in unaudited gross revenue over the first nine months of 2020 and a net profit of C$104,000. Pure Therapy has also acquired more than 3,000 new customers over the same period. The acquisition will now provide BevCanna with a steady and growing revenue stream.
For the benefit of actual investors / potential investors, Bevcanna is a start-up and having recently obtained said license from HC is now in a position to start generating significant revenue. One recent example (taken from Sedar) to show Bevcanna is not pre-revenue is below.
Also, the outstanding share count is 100M which is low in comparison to many peers in this growing space.
VANCOUVER, BC, Oct. 9, 2020 /CNW/ - Emerging leader in infused cannabis beverages,BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) ("BevCanna" or the"Company") announced today that its wholly owned subsidiary, Pure Therapy Products Corp. ("PureTherapy") has generated C$1.53 million in unaudited gross revenue over the first nine months of 2020 and a net profit of C$104,000. Pure Therapy has also acquired more than 3,000 new customers over the same period. The acquisition will now provide BevCanna with a steady and growing revenue stream.
Recent VNTXF News
- Vanta Announces Strategic Agreement to Support U.S. Peptide Market Entry Through FDA-Registered Supply Chain and Compliant Payment Processing Infrastructure; Advancing U.S.-Focused Longevity and Consumer Health Sciences Platform • ACCESS Newswire • 05/29/2026 12:10:00 AM
- Vanta Announces Closing of Second Tranche of Private Placement for Aggregate Gross Proceeds of $1 Million • ACCESS Newswire • 05/06/2026 08:00:00 PM
- Vanta Announces Closing of First Tranche of Private Placement and Debt Settlement • ACCESS Newswire • 05/06/2026 12:00:00 AM
- Vanta Announces U.S. Ticker Symbol Change to VNTXF • ACCESS Newswire • 03/26/2026 07:05:00 AM
- Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives • ACCESS Newswire • 03/26/2026 03:55:00 AM
